[
(Reuters) – Bayer (OTC:)’s Monsanto (NYSE:) unit said on Wednesday that a Philadelphia Court jury reached a verdict in the Young Roundup product liability trial in their favor.
Bayer bought Monsanto for $63 billion in 2018, and has faced extensive and costly litigation over whether Monsanto’s Roundup weed killer causes cancer.
https://i-invdn-com.investing.com/news/LYNXNPEBAG0BO_L.jpg
https://www.investing.com/news/stock-market-news/jury-rules-in-favor-of-bayers-monsanto-in-philadelphia-trial-over-roundup-3612538
Reuters